Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Science (New York, N.Y.)|May 15, 1999
Bone marrow as a potential source of hepatic oval cellsB E Petersen, W C Bowen, K D Patrene, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|June 26, 2018
Systematic review of the evidence for sustained efficacy of dietary interventions for reducing appetite or energy intakeJ C G Halford, U Masic, C F M Marsaux, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzeneShashikiran Donthamsetty, Vishakha S Bhave, Corrine S Kliment, et al.
Hepatology (Baltimore, Md.)|July 19, 2005
The role of hepatic type 1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shockClaudio E Lagoa, Yoram Vodovotz, Donna B Stolz, et al.
Cancer Causes & Control : CCC|April 21, 2021
The implementation of a national paediatric oncology protocol for neuroblastoma in South AfricaJaques van Heerden, Marc Hendricks, Janet Poole, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|June 17, 2011
Effects of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomized controlled trialsA J Wanders, J J G C van den Borne, C de Graaf, et al.
The American Journal of Pathology|May 6, 2019
A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced DiabetesGina M Coudriet, John Stoops, Anne V Orr, et al.
Hepatology (Baltimore, Md.)|October 11, 2008
Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegalyVasiliki Gkretsi, Udayan Apte, Wendy M Mars, et al.
Pageof 27